MN HF 2851
died on adjournmentReverse auction procurement requirement for SEGIP pharmacy benefit contracts modified, use of spread pricing by pharmacy benefit managers prohibited, license application fees increased, fiduciary duties imposed, and money appropriated.
Minnesota · 2025-2026 · lower
Quick answers
Did MN HF 2851 pass?
No. MN HF 2851 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-26): Author added Johnson, P.
What is MN HF 2851 about?
MN HF 2851 is a bill in the 2025-2026 titled “Reverse auction procurement requirement for SEGIP pharmacy benefit contracts modified, use of spread pricing by pharmacy benefit managers prohibited, license application fees increased, fiduciary duties imposed, and money appropriated.”.
Who sponsors MN HF 2851?
Elkins is the primary sponsor of MN HF 2851, joined by 1 cosponsor.
- Introduced
- 2025-03-26
- Latest action
- 2026-02-26 — Author added Johnson, P.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Elkinsprimary
- Johnson, P.cosponsor
Committees
Not provided by source.
Action timeline
2025-03-26
Introduction and first reading, referred to Health Finance and Policy
introduction,referral-committee
2026-02-26
Author added Johnson, P.
Versions
- Introduction — 2025-03-25Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SF 3063
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=HF 2851. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.